Active GMP Recombinant Human FGF7 protein

Specification :
| Source : E. coli | Species : Human | Tag : N/A | Form : Lyophilized from a 0.2 µm filtered solution in 20mM PB, pH 7.4, 500 mM NaCl, 0.02 % Tween-20. | Bio-activity : Fully biologically active when compared to standard. The ED50 as determined by thymidine uptake assay using FGF-receptors transfected BaF3 cells is less than 10 ng/ml, corresponding to a specific activity of > 1.0 × 105 IU/mg. | Molecular Mass : Approximately 18.9 kDa, a single, non-glycosylated polypeptide chain containing 163 amino acids. | AA Sequence : CNDMTPEQMA TNVNCSSPER HTRSYDYMEG GDIRVRRLFC RTQWYLRIDK RGKVKGTQEM KNNYNIMEIR TVAVGIVAIK GVESEFYLAM NKEGKLYAKK ECNEDCNFKE LILENHYNTY ASAKWTHNGG EMFVALNQKG IPVRGKKTKK EQKTAHFLPM AIT | Endotoxin : Less than 0.01 EU/μg of rHuNRG1-β2 GMP as determined by LAL method. | Purity : > 98 % by SDS-PAGE and HPLC analyses. | Storage : Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution. | Reconstitution : Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.